TY - JOUR
T1 - AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia
AU - Ruozi, Giulia
AU - Bortolotti, Francesca
AU - Falcione, Antonella
AU - Dal Ferro, Matteo
AU - Ukovich, Laura
AU - MacEdo, Antero
AU - Zentilin, Lorena
AU - Filigheddu, Nicoletta
AU - Cappellari, Gianluca Gortan
AU - Baldini, Giovanna
AU - Zweyer, Marina
AU - Barazzoni, Rocco
AU - Graziani, Andrea
AU - Zacchigna, Serena
AU - Giacca, Mauro
N1 - Publisher Copyright:
© 2015 Macmillan Publishers Limited. All rights reserved.
PY - 2015/6/11
Y1 - 2015/6/11
N2 - Functional screening of expression libraries in vivo would offer the possibility of identifying novel biotherapeutics without a priori knowledge of their biochemical function. Here we describe a procedure for the functional selection of tissue-protective factors based on the in vivo delivery of arrayed cDNA libraries from the mouse secretome using adeno-associated virus (AAV) vectors. Application of this technique, which we call FunSel, in the context of acute ischaemia, revealed that the peptide ghrelin protects skeletal muscle and heart from ischaemic damage. When delivered to the heart using an AAV9 vector, ghrelin markedly reduces infarct size and preserves cardiac function over time. This protective activity associates with the capacity of ghrelin to sustain autophagy and remove dysfunctional mitochondria after myocardial infarction. Our findings describe an innovative tool to identify biological therapeutics and reveal a novel role of ghrelin as an inducer of myoprotective autophagy.
AB - Functional screening of expression libraries in vivo would offer the possibility of identifying novel biotherapeutics without a priori knowledge of their biochemical function. Here we describe a procedure for the functional selection of tissue-protective factors based on the in vivo delivery of arrayed cDNA libraries from the mouse secretome using adeno-associated virus (AAV) vectors. Application of this technique, which we call FunSel, in the context of acute ischaemia, revealed that the peptide ghrelin protects skeletal muscle and heart from ischaemic damage. When delivered to the heart using an AAV9 vector, ghrelin markedly reduces infarct size and preserves cardiac function over time. This protective activity associates with the capacity of ghrelin to sustain autophagy and remove dysfunctional mitochondria after myocardial infarction. Our findings describe an innovative tool to identify biological therapeutics and reveal a novel role of ghrelin as an inducer of myoprotective autophagy.
UR - http://www.scopus.com/inward/record.url?scp=84931281543&partnerID=8YFLogxK
U2 - 10.1038/ncomms8388
DO - 10.1038/ncomms8388
M3 - Article
SN - 2041-1723
VL - 6
JO - Nature Communications
JF - Nature Communications
M1 - 7388
ER -